Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Calugareanu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|December 22, 2021
Extensive cutaneous lichen planus triggered by viral vector COVID-19 vaccination (ChAdOx1 nCoV-19)C Masseran, A Calugareanu, F Caux, et al.
Contact Dermatitis|December 26, 2023
Ceftaroline-induced DRESS syndrome associated with possible lung involvementV Bourdonnet, G Dupire, A Calugareanu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 21, 2019
Dramatic improvement of generalized prurigo nodularis with dupilumabA Calugareanu, M Jachiet, C Lepelletier, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 4, 2022
Dramatic response to dupilumab in papular amyloidosisS Zahid, A Saussine, A Calugareanu, et al.
Annales De Dermatologie Et De Venereologie|April 27, 2020
[Cutaneous plasmacytosis with Darier's sign in a woman of European origin]A Calugareanu, F Cordoliani, M Battistella, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 28, 2021
Clinical efficacy of selective JAK1 inhibition and transcriptome analysis of chronic discoid lupus erythematosusA Calugareanu, C Grolleau, H Le Buanec, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 19, 2019
Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patientsA Calugareanu, M Jachiet, M Tauber, et al.
La Revue De Medecine Interne|July 23, 2022
Neutrophilic dermatosesJ Delaleu, C Lepelletier, A Calugareanu, et al.
The British Journal of Dermatology|October 6, 2021
Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreakL Frumholtz, J-D Bouaziz, M Battistella, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of the European Academy of Dermatology and Venereology : JEADV|December 22, 2021
Extensive cutaneous lichen planus triggered by viral vector COVID-19 vaccination (ChAdOx1 nCoV-19)C Masseran, A Calugareanu, F Caux, et al.
Contact Dermatitis|December 26, 2023
Ceftaroline-induced DRESS syndrome associated with possible lung involvementV Bourdonnet, G Dupire, A Calugareanu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 21, 2019
Dramatic improvement of generalized prurigo nodularis with dupilumabA Calugareanu, M Jachiet, C Lepelletier, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 4, 2022
Dramatic response to dupilumab in papular amyloidosisS Zahid, A Saussine, A Calugareanu, et al.
Annales De Dermatologie Et De Venereologie|April 27, 2020
[Cutaneous plasmacytosis with Darier's sign in a woman of European origin]A Calugareanu, F Cordoliani, M Battistella, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 28, 2021
Clinical efficacy of selective JAK1 inhibition and transcriptome analysis of chronic discoid lupus erythematosusA Calugareanu, C Grolleau, H Le Buanec, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 19, 2019
Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patientsA Calugareanu, M Jachiet, M Tauber, et al.
La Revue De Medecine Interne|July 23, 2022
Neutrophilic dermatosesJ Delaleu, C Lepelletier, A Calugareanu, et al.
The British Journal of Dermatology|October 6, 2021
Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreakL Frumholtz, J-D Bouaziz, M Battistella, et al.
Pageof 1